Verzenio + Faslodex Improves Survival in Advanced, HR+, HER2- BC

Options
Moderators
Moderators Member Posts: 25,912

Verzenio Plus Faslodex Improves Overall Survival by 9 Months in Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer
September 30, 2019

Latest results from MONARCH 2 study show adding Verzenio to Faslodex improves overall survival by 9 months for advanced-stage, hormone-receptor-positive, HER2-negative breast cancer. Read more...

Categories